176 related articles for article (PubMed ID: 36102872)
1. Intranuclear Nanoribbons for Selective Killing of Osteosarcoma Cells.
Liu S; Zhang Q; He H; Yi M; Tan W; Guo J; Xu B
Angew Chem Int Ed Engl; 2022 Nov; 61(44):e202210568. PubMed ID: 36102872
[TBL] [Abstract][Full Text] [Related]
2. Intranuclear assembly of leucine-rich peptides for selective death of osteosarcoma cells.
Liu S; Zhang Q; Peng X; Hu C; Wang S; Sun Y
Biomater Sci; 2024 Feb; 12(5):1274-1280. PubMed ID: 38251092
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Enzymatic Dephosphorylation Kinetics in the Assemblies of a Phosphopentapeptide that Forms Intranuclear Nanoribbons.
Qiao Y; Wu G; Liu Z; He H; Tan W; Xu B
Biomacromolecules; 2024 Feb; 25(2):1310-1318. PubMed ID: 38265878
[TBL] [Abstract][Full Text] [Related]
4. Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells.
Liu S; Zhang Q; Shy AN; Yi M; He H; Lu S; Xu B
J Am Chem Soc; 2021 Sep; 143(38):15852-15862. PubMed ID: 34528792
[TBL] [Abstract][Full Text] [Related]
5. Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance.
Wang H; Feng Z; Wang Y; Zhou R; Yang Z; Xu B
J Am Chem Soc; 2016 Dec; 138(49):16046-16055. PubMed ID: 27960313
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic Assemblies of Thiophosphopeptides Instantly Target Golgi Apparatus and Selectively Kill Cancer Cells*.
Tan W; Zhang Q; Wang J; Yi M; He H; Xu B
Angew Chem Int Ed Engl; 2021 Jun; 60(23):12796-12801. PubMed ID: 33783926
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Continuum of Nanoscale Peptide Assemblies Facilitates Endocytosis and Endosomal Escape.
He H; Guo J; Xu J; Wang J; Liu S; Xu B
Nano Lett; 2021 May; 21(9):4078-4085. PubMed ID: 33939437
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-Instructed Self-Assembly of Small D-Peptides as a Multiple-Step Process for Selectively Killing Cancer Cells.
Zhou J; Du X; Yamagata N; Xu B
J Am Chem Soc; 2016 Mar; 138(11):3813-23. PubMed ID: 26966844
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent gold nanocluster-based sensor for detection of alkaline phosphatase in human osteosarcoma cells.
Deng HH; Deng Q; Li KL; Zhuang QQ; Zhuang YB; Peng HP; Xia XH; Chen W
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 229():117875. PubMed ID: 31813715
[TBL] [Abstract][Full Text] [Related]
10. Bioinspired Tumor-Targeting and Biomarker-Activatable Cell-Material Interfacing System Enhances Osteosarcoma Treatment via Biomineralization.
Yang X; Gao S; Yang B; Yang Z; Lou F; Huang P; Zhao P; Guo J; Fang H; Chu B; He M; Wang N; Chan AHL; Chan RHF; Wang Z; Bian L; Zhang K
Adv Sci (Weinh); 2023 Aug; 10(22):e2302272. PubMed ID: 37211693
[TBL] [Abstract][Full Text] [Related]
11. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-Instructed Peptide Assembly Favored by Preorganization for Cancer Cell Membrane Engineering.
Ding Y; Zheng D; Xie L; Zhang X; Zhang Z; Wang L; Hu ZW; Yang Z
J Am Chem Soc; 2023 Mar; 145(8):4366-4371. PubMed ID: 36669158
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics.
Low SA; Yang J; Kopeček J
Bioconjug Chem; 2014 Nov; 25(11):2012-20. PubMed ID: 25291150
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
[TBL] [Abstract][Full Text] [Related]
16. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
19. Expression and nature of the alkaline phosphatase gene in cultured osteosarcoma cells.
Stinson RA; Thacker JD; Lin CC
Clin Chim Acta; 1993 Nov; 221(1-2):105-14. PubMed ID: 7512000
[TBL] [Abstract][Full Text] [Related]
20. Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.
Li Y; Qu J; Zhang P; Zhang Z
Nanotechnology; 2020 Nov; 31(45):455101. PubMed ID: 32688350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
